Reduction of alpha-synuclein oligomers in preclinical models of Parkinson’s disease by electrical stimulation in vitro and deep brain stimulation in vivo
Background: Deep brain stimulation (DBS) has been widely used to manage debilitating neurological symptoms in movement disorders such as Parkinson's disease (PD). Despite its well-established symptomatic benefits, our understanding of the mechanisms underlying DBS and its possible effect on the accu...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2024-03-01
|
| Collection: | Brain Stimulation |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S1935861X24000160 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
